SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-014169
Filing Date
2010-02-18
Accepted
2010-02-18 17:02:38
Documents
4
Period of Report
2010-02-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w77426e8vk.htm 8-K 13439
2 EX-99.1 w77426exv99w1.htm EX-99.1 8638
3 EX-99.2 w77426exv99w2.htm EX-99.2 5899
4 GRAPHIC w77426w7742601.gif GRAPHIC 10940
  Complete submission text file 0000950123-10-014169.txt   44941
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 10617052
SIC: 2836 Biological Products, (No Diagnostic Substances)